Agfa-Gevaert NV’s (EBR:AGFB) Share Price Is Matching Sentiment Around Its Revenues

You may think that with a price-to-sales (or “P/S”) ratio of 0.2x Agfa-Gevaert NV (EBR:AGFB) is a stock worth checking out, seeing as almost half of all the Healthcare Services companies in Belgium have P/S ratios greater than 2.1x and even P/S higher than 6x aren’t out of the ordinary. Although, it’s not wise to just take the P/S at face value as there may be an explanation why it’s limited.

View our latest analysis for Agfa-Gevaert

ps-multiple-vs-industry
ENXTBR:AGFB Price to Sales Ratio vs Industry July 25th 2025

How Has Agfa-Gevaert Performed Recently?

With revenue growth that’s inferior to most other companies of late, Agfa-Gevaert…

Source link